Viral load in the natural history of human papillomavirus type 16 infection: a nested case-control study

J Infect Dis. 2011 May 15;203(10):1425-33. doi: 10.1093/infdis/jir049. Epub 2011 Mar 16.

Abstract

Background: Viral load may influence the course of human papillomavirus type 16 (HPV-16) infection.

Methods: This case-control study was nested within the 2-year Atypical Squamous Cells of Undetermined Significance and Low-Grade Squamous Intraepithelial Lesion Triage Study, in which women were followed semiannually for HPV and cervical intraepithelial neoplasia (CIN). Case patients (n = 62) were women diagnosed with CIN3 following HPV-16-positive detection at a follow-up visit. HPV-16-positive controls (n = 152) without CIN2 or CIN3 were matched to cases based on the follow-up visit in which viral load was measured. Real-time polymerase chain reaction was used for HPV-16 DNA quantification.

Results: The risk of CIN3 increased with increasing HPV-16 DNA load at the follow-up visit (odds ratio, 1.63; 95% confidence interval, 1.33-1.99 per 1 log(10) unit increase); the association was not affected by whether HPV-16 was present at enrollment. When HPV-16 was present at both enrollment and follow-up, viral load remained high among cases (P = .77) but decreased substantially among controls (P = .004). Among women with HPV-16 found initially during follow-up, viral load in the first HPV-16-positive sample was associated with short-term persistence; load was higher in those with infection, compared with those without infection, 1 visit after the initial positivity (P = .001).

Conclusions: Viral load of newly detected infections and changes in viral load predict persistence and progression of HPV-16 infections.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Adult
  • Case-Control Studies
  • DNA, Viral / analysis
  • Female
  • Human papillomavirus 16*
  • Humans
  • Longitudinal Studies
  • Odds Ratio
  • Papillomavirus Infections / virology*
  • Uterine Cervical Dysplasia / virology*
  • Uterine Cervical Neoplasms / virology*
  • Viral Load*
  • Young Adult

Substances

  • DNA, Viral